Clene Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CLNN | GANX | CGTX | PMN | LONA | ALEC | |
|---|---|---|---|---|---|---|
| Market cap | 58.28M | 48.44M | 64.98M | 31.57M | 43.01M | 254.58M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.7 | -1.6 | -3.1 | -0.8 | — | -3.1 |
| Price/book | -2.5 | 4.3 | 2.0 | 0.6 | 1.3 | -25.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −55.68% | −41.58% | −58.86% | −63.90% | +13.84% | +75.38% |
| Today | +8.75% | −3.48% | −2.32% | +3.23% | −4.30% | +11.22% |
The closest companies by business and industry (Packaged Foods). Prices may be delayed up to 15 min.
Latest news
All CLNN news ›Clene (NASDAQ:CLNN) versus SCYNEXIS (NASDAQ:SCYX) Head to Head Comparison
Posted by Sarita Garza on Nov 2nd, 2026 Clene (NASDAQ:CLNN – Get Free Report) and SCYNEXIS (NASDAQ:SCYX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based…
Clene Inc. (NASDAQ:CLNN) Stock Short Interest Declines 51.8%
Posted by Kim Johansen on Nov 1st, 2026 Clene Inc. (NASDAQ:CLNN – Get Free Report) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totaling 424,864 shares, a drop of 51.8% from…
Financial Comparison: Clene (NASDAQ:CLNN) and Theravance Biopharma (NASDAQ:TBPH)
Posted by Kim Johansen on Nov 1st, 2026 Theravance Biopharma (NASDAQ:TBPH – Get Free Report) and Clene (NASDAQ:CLNN – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two…
Zevra Therapeutics (NASDAQ:ZVRA) & Clene (NASDAQ:CLNN) Head to Head Review
Posted by Defense World Staff on Oct 25th, 2026 Zevra Therapeutics (NASDAQ:ZVRA – Get Free Report) and Clene (NASDAQ:CLNN – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two…
Clene Announces Peer-Reviewed Publication Describing CNM-Au8 Catalytic Neuroprotective Mechanism of Action
Novel catalytic mechanism of CNM-Au8 reveals its promise as a versatile new treatment to address multiple assaults on neuronal health in neurodegenerative diseases SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq:…
Will Clene's Gold Nanocrystal Therapy Earn A Place In The ALS Treatment Arsenal?
Neuronal decline is a natural part of ageing. In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), this decline is accelerated and compounded by energy deficits, which contribute to neuronal dysfunction and ultimately…
Clene Reports Significant Long-Term Survival Improvement From CNM-Au8 Treatment in HEALEY ALS Platform Trial Compared to PRO-ACT Historical Controls
Prolonged life with 49% decreased risk of death for participants in the HEALEY ALS Platform Trial treated with CNM-Au8 ® 30mg compared to PRO-ACT matched placebo over long-term follow-up, p=0.046 Prolonged life with 59% decreased risk of…
Clene seeks FDA accelerated approval of oral ALS treatment
Data suggest CNM-Au8 lowers NfL levels in blood Written by Michela Luciano, PhD | Oct. 20, 2026 Clene Nanomedicine has submitted an application to the U.S. Food and Drug Administration (FDA) seeking accelerated approval of its experimental…
Clene Submits New Biomarker and Efficacy Data on ALS Treatment CNM-Au8 to FDA
Long-term treatment with Clene Nanomedicine’s CNM-Au8 was associated with improved survival among patients with amyotrophic lateral sclerosis from 2 clinical trials. In its announcement, Clene noted that these data are intended to be a…
Clene Receives FDA Guidance on Accelerated Approval Pathway for CNM-Au8 in ALS, Plans Further Biomarker Analysis
The FDA recommended a follow-up meeting with Clene to further discuss the analyses needed to support the accelerated approval pathway for CNM-Au8 in amyotrophic lateral sclerosis.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com5
- stocktitan.net3
- defenseworld.net2
- developingtelecoms.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.